Patricia E Daly1, Sara Samiee2, Maria Cino3, Robert Gryfe4, Aaron Pollett5, Andrea Ng6, Louis S Constine7, David C Hodgson1,8. 1. Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. 2. Hematology Oncology and BMT Research Centre, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. 3. Department of Gastroenterology, Toronto Western Hospital, Toronto, Ontario, Canada. 4. Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada. 5. Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada. 6. Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA. 7. Department of Radiation Oncology, University of Rochester Medical Center, Rochester, New York, USA. 8. Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
Abstract
OBJECTIVE: Cancer survivors treated with abdominal/pelvic radiation therapy (ART) have increased the risks of colorectal cancer (CRC), although evidence supporting early CRC screening for these patients is lacking. We sought to determine whether there is an elevated prevalence of adenomatous colorectal polyps in young survivors prior to the age when screening would be routinely recommended. DESIGN: We conducted a prospective study of early colonoscopic screening in cancer survivors aged 35-49 who had received ART ≥10 years previously. The planned sample size was based on prior studies reporting a prevalence of adenomatous polyps of approximately 20% among the average-risk population ≥50 years of age, in contrast to ≤10% among those average-risk people aged 40-50 years, for whom screening is not routinely recommended. RESULTS: Colonoscopy was performed in 54 survivors, at a median age of 45 years (range 36-49) and after median interval from radiation treatment of 19 years (10.6-43.5). Forty-nine polyps were detected in 24 patients, with 15 patients (27.8%; 95% CI 17.6% to 40.9%) having potentially precancerous polyps. Fifty-three per cent of polyps were within or at the edge of the prior ART fields. CONCLUSIONS: Young survivors treated with ART have a polyp prevalence comparable with the average-risk population aged ≥50 years and substantially higher than previously reported for the average-risk population aged 40-50 years. These findings lend support to the early initiation of screening in these survivors. CLINICAL TRIAL REGISTRATION NUMBER: NCT00982059; results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
OBJECTIVE:Cancer survivors treated with abdominal/pelvic radiation therapy (ART) have increased the risks of colorectal cancer (CRC), although evidence supporting early CRC screening for these patients is lacking. We sought to determine whether there is an elevated prevalence of adenomatous colorectal polyps in young survivors prior to the age when screening would be routinely recommended. DESIGN: We conducted a prospective study of early colonoscopic screening in cancer survivors aged 35-49 who had received ART ≥10 years previously. The planned sample size was based on prior studies reporting a prevalence of adenomatous polyps of approximately 20% among the average-risk population ≥50 years of age, in contrast to ≤10% among those average-risk people aged 40-50 years, for whom screening is not routinely recommended. RESULTS: Colonoscopy was performed in 54 survivors, at a median age of 45 years (range 36-49) and after median interval from radiation treatment of 19 years (10.6-43.5). Forty-nine polyps were detected in 24 patients, with 15 patients (27.8%; 95% CI 17.6% to 40.9%) having potentially precancerous polyps. Fifty-three per cent of polyps were within or at the edge of the prior ART fields. CONCLUSIONS: Young survivors treated with ART have a polyp prevalence comparable with the average-risk population aged ≥50 years and substantially higher than previously reported for the average-risk population aged 40-50 years. These findings lend support to the early initiation of screening in these survivors. CLINICAL TRIAL REGISTRATION NUMBER: NCT00982059; results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Entities:
Keywords:
COLONOSCOPY; COLORECTAL CANCER; COLORECTAL CANCER SCREENING
Authors: Judith L Kok; Jop C Teepen; Helena J van der Pal; Flora E van Leeuwen; Wim J E Tissing; Sebastian J C M M Neggers; Jacqueline J Loonen; Marloes Louwerens; Birgitta Versluys; Marry M van den Heuvel-Eibrink; Eline van Dulmen-den Broeder; Monique M W Jaspers; Hanneke M van Santen; Margriet van der Heiden-van der Loo; Geert O Janssens; John H Maduro; Annette H Bruggink; Marjolijn C Jongmans; Leontien C M Kremer; Cécile M Ronckers Journal: JAMA Oncol Date: 2019-05-01 Impact factor: 31.777
Authors: Berbel L M Ykema; Lisanne S Rigter; Manon C W Spaander; Leon M G Moons; Tanya M Bisseling; Berthe M P Aleman; Evelien Dekker; Wieke H M Verbeek; Ernst J Kuipers; Jan Paul de Boer; Pieternella J Lugtenburg; Cecile P M Janus; Eefke J Petersen; Judith M Roesink; Richard W M van der Maazen; Gerrit A Meijer; Michael Schaapveld; Flora E van Leeuwen; Beatriz Carvalho; Petur Snaebjornsson; Monique E van Leerdam Journal: Dig Endosc Date: 2021-06-08 Impact factor: 6.337
Authors: Lisanne S Rigter; Manon C W Spaander; Berthe M P Aleman; Tanya M Bisseling; Leon M Moons; Annemieke Cats; Pieternella J Lugtenburg; Cecile P M Janus; Eefke J Petersen; Judith M Roesink; Richard W M van der Maazen; Petur Snaebjornsson; Ernst J Kuipers; Marco J Bruno; Evelien Dekker; Gerrit A Meijer; Jan Paul de Boer; Flora E van Leeuwen; Monique E van Leerdam Journal: Cancer Date: 2018-12-18 Impact factor: 6.860
Authors: Andrea Gini; Reinier G S Meester; Homa Keshavarz; Kevin C Oeffinger; Sameera Ahmed; David C Hodgson; Iris Lansdorp-Vogelaar Journal: J Natl Cancer Inst Date: 2019-11-01 Impact factor: 13.506